A new home-use device to help monitor lung function and COVID-19 cases
Thorasys is pleased to announce the signature of a worldwide exclusive licensing agreement for the acquisition of REOM technology from Spiro-tech Inc.
Press release COVID-19 (april 2020)
Thorasys wants to help the early detection of exacerbation in patients with respiratory diseases including COVID-19.
THORASYS Update regarding COVID-19
The global pandemic of COVID-19 is growing and affects all aspects of the society.
Thorasys Ships Its First System for Newborn Investigational Tests
It is with enthusiasm that we are making the tremoflo N-100 available for research purpose for the study of respiratory function in toddlers, especially from their very first days.
Appointment of a New Member
THORASYS Chairman Marcel Larochelle is pleased to announce the appointment of Mr. Yvan Beaudoin as President and CEO of THORASYS Inc. effective September 1, 2017.